Cargando…
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study
The C–C motif chemokine receptor-5 (CCR5) expression on the T-cell surface is the prime barrier to HIV/AIDS eradication, as it promotes both active human immunodeficiency virus (HIV)-infection and latency; however, antiretrovirals (ARVs) suppress plasma viral loads to non-detectable levels. Keeping...
Autores principales: | Mandal, Subhra, Sunagawa, Shawnalyn W., Prathipati, Pavan Kumar, Belshan, Michael, Shibata, Annemarie, Destache, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183115/ https://www.ncbi.nlm.nih.gov/pubmed/35683795 http://dx.doi.org/10.3390/nano12111942 |
Ejemplares similares
-
2501. CCR5 Targeted ARV Loaded Nanoparticle: Dual Protection for HIV Functional Cure
por: Destache, Christopher J, et al.
Publicado: (2019) -
Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
por: Mandal, Subhra, et al.
Publicado: (2017) -
Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis
por: Khandalavala, Karl, et al.
Publicado: (2017) -
Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
por: Perazzolo, Simone, et al.
Publicado: (2020) -
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
por: Destache, Christopher J, et al.
Publicado: (2009)